Solr Search

rmations are disrupting the status quo.

lop a standardised set of information that investors and companies can use in their decision-making process.

tinued by drug companies for nonscientific reasons, including strategic, organizational, and financial considerations.

rt Financial Innovations Labs® series.

alled tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and the , At present, no disease-modifying therapies for the pure tauopathies exist. Researchers are working to develop effective therapeutic agents, which include approaches such as decreasing the amount of tau within the brain., Symptomatic Interventions At present, no disease-modifying therapies for the pure tauopathies exist.

changed how consumers and businesses transact, interact, and access financial services.

entrepreneurs seeking to address the inefficiencies and lack of customer-centricity in the current ecosystem.

with financial services and products.

re remain multiple bipartisan legislative opportunities to drive FinTech policy forward that address hurdles preventing startups and incumbents from harne

eader in industries ranging from agriculture to financial services, tourism, and technology.

ed to technological change in the past and how current innovative projects are supporting adaptation, especially in the private sector.

ers such as product developers and regulators to define and implement the “how to” of patient